DIN 02183013 — VINCRISTINE SULFATE INJECTION USP 1 MG
VINCRISTINE SULFATE INJECTION USP is a solution of Vincristine marketed by PFIZER CANADA ULC. The full Vincristine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02183013
- Brand name
- VINCRISTINE SULFATE INJECTION USP
- Active ingredient
- Vincristine
- Strength
- 1 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- PFIZER CANADA ULC
- Health Canada status
- MARKETED
- Drug class
- Vinca alkaloid antineoplastic agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Vincristine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02143305 | VINCRISTINE SULFATE INJECTION | 1 MG | SOLUTION | TEVA CANADA LIMITED | MARKETED |